Promus PREMIER™ H7493952808250Recalls & reported problems
Boston Scientific Corporation · Everolimus-Eluting Platinum Chromium Coronary Stent System · Class 3 · Implant
All models of Promus PREMIER (56)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 08714729844594), received between Apr 11, 2017 and Oct 8, 2018 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Bent” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Bent1
- Detachment of Device or Device Component1
Patient problems
- No Consequences Or Impact To Patient2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryOct 8, 2018Detachment of Device or Device Component; Detachment of Device or Device Component
IT WAS REPORTED THAT STENT DISLODGMENT OCCURRED. THE TARGET LESION WAS A RESTENOSIS OF A PREVIOUSLY IMPLANTED NON-BSC STENT IN THE CALCIFIED PROXIMAL CIRCUMFLEX ARTERY ONE MONTH AGO. THERE WAS A CHUNK OF CALCIUM PROXIMAL TO THE STENT. AFTER PRE-DILATATION WAS PERFORMED WITH A 2.5X15MM NC EMERGE BALLOON CATHETER AT 20 ATMOSPHERES, A 2.50X8MM PROMUS PREMIER WAS ADVANCED BUT FAILED TO CROSS THE LESION. THE PHYSICIAN DECIDED TO PULL THE DEVICE OUT; HOWEVER, AFTER MULTIPLES ATTEMPTS TO GET THE DEVICE OUT, THE PHYSICIAN FELT A POP. UPON INSPECTION, IT WAS NOTED THAT THE STENT CAME OFF THE BALLOON AND WAS STUCK IN THE CALCIUM PROXIMAL TO THE LESION. A 2.5X12MM EMERGE BALLOON CATHETER WAS THEN ADVANCED AND USED TO DEPLOY THE STENT IN A NORMAL FASHION WITH EXCELLENT RESULTS. NO PATIENT COMPLICATIONS NOR BLOOD LOSS WERE REPORTED. THE DEVICE WAS NOT RETURNED. THE MANUFACTURING BATCH RECORD REVIEW CONFIRMED THAT THE DEVICE MET ALL MATERIAL, ASSEMBLY AND PERFORMANCE SPECIFICATIONS. THE INVESTIGATION CONCLUSION IS ADVERSE EVENT RELATED TO PATIENT CONDITION.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7944909 ↗MalfunctionApr 11, 2017Bent; Bent
IT WAS REPORTED THAT STENT DAMAGE OCCURRED. THE TARGET LESION WAS LOCATED IN A CORONARY ARTERY. A 2.50 X 8 MM PROMUS PREMIER¿ DRUG-ELUTING STENT WAS USED FOR TREATMENT. HOWEVER, DURING THE PROCEDURE, IT WAS NOTED THAT THE TIP OF THE STENT APPEARED DEFORMED. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6481848 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page